Skip
UTPhysicians logoUT Physicians - a part of UTHealth

888-4UT-DOCS | 888-488-3627

  • About Us
    About UT Physicians Careers Contact Us News Health Programs/Services Patient Stories Videos
  • Find a Provider / Clinic
    Search By Specialty Search Providers Search By Name Search By Location
  • Patient Information
    About your Visit Billing Information Clinical Trials Insurance Refer a patient Make an Appointment International Patients Medical Records Legal Billing Records
  • Health Programs/Services
  • Make an Appointment
  • Pay My Bill
  • MyUTP Portal
  • Careers

UTHealth Research

Other Categories
  • Cardiothoracic & Vascular Surgery
  • Children's Health Stories
  • Coronavirus
  • Coronavirus Español
  • COVID-19 Patient Resources
  • Ear, Nose, and Throat Stories
  • Epilepsy
  • Featured
  • Heart Care
  • In the Media
  • In the Media Español
  • News
  • Orthopedics
  • Patient Stories
  • Pediatric Surgery
  • UTHealth COVID-19 Research
  • UTHealth Research
  • Women's Health Stories
  • Prev
  • 1
  • 2
  • 3
  • Next

Heart month: Researchers create Texas’ first statewide cardiac arrest registry, highlight racial disparities in CPR training

Photo of Salil Bhandari, MD, demonstrating how to do bystander CPR safely during the COVID-19 pandemic. (Photo by UTHealth)

Projections from Texas’ first cardiac arrest registry show that every day at least 60 Texans will suffer an out-of-hospital cardiac arrest, which is a sudden loss of heart function, breathing, and consciousness. If bystander cardiopulmonary resuscitation (CPR) is performed, the victim’s chance of survival can triple, but less than half of victims in the Lone Star State receive any bystander CPR, according to data from the registry.

Read full article
  • First Houston post-coronavirus clinic part of new UTHealth COVID-19 Center of Excellence Photo of UTHealth researchers and physicians, from left, Luis Ostrosky, MD; Bela Patel, MD; and Henry Wang, MD, MPH, are leading clinical trials on COVID-19. (Photo by Maricruz Kwon/UTHealth)

    Bringing together expertise and access to the best clinical care, research trials, discovery science, and public health knowledge, The University of Texas Health Science Center at Houston (UTHealth) has established the UTHealth COVID-19 Center of Excellence.

  • Researchers studying new nonsurgical treatment for chronic sinusitis Sneezing Woman

    Researchers at The University of Texas Health Science Center at Houston (UTHealth) are investigating the efficacy and safety of an intranasal treatment for adults with chronic sinusitis with or without nasal polyps.

  • Clinical trial to assess rehabilitation treatment for infants and toddlers after stroke Therapist Kelsey Burke of the Fralin Biomedical Research Institute Neuromotor Research Clinic works with a young patient using I-ACQUIRE therapy. (Photo by: Fralin Biomedical Research Institute)

    In the first of its kind for the tiniest stroke survivors, researchers at The University of Texas Health Science Center at Houston (UTHealth) will lead a stroke rehabilitation clinical trial in the state of Texas through a multi-institutional NIH StrokeNet initiative.

  • Placenta accreta month: Novel approach to life-threatening pregnancy condition allows woman to have “miracle child” after loss Placenta accreta patient, Margarita Saavedra Margarita Saavedra was 35 years old and 18 weeks pregnant with her second child when she fainted at the doctor’s office after receiving the news that she might need to have a hysterectomy to remove her uterus.
  • Could the time of day impact the effectiveness of COVID-19 treatment? Medication Time

    For months, experts have warned against the use of anti-inflammatory medications, such as ibuprofen, to treat COVID-19 symptoms. But could the timing of when this drug is taken play a role in its effectiveness?

  • Young Houston woman recovers from COVID-19 after participation in two UTHealth clinical trials Photo of Bindu Akkanti, MD, who discusses the benefit of academic medicine after one of her patients, who was enrolled in two clinical trials, recovers from COVID-19. (Photo credit: Bindu Akkanti, MD) Heba Hajjar, 23, recovered from COVID-19 after participating in two clinical trials through The University of Texas Health Science Center at Houston (UTHealth) while in the intensive care unit (ICU) at Memorial Hermann-Texas Medical Center. She was so weak she couldn’t move or sit up in bed. She was cautiously monitored on oxygen therapy and […]
  • Researchers assess whether blood plasma product could reduce hemorrhaging, improve survival rate of trauma patients Medical Professional Holding Plasma IV The early use of a highly concentrated blood plasma called cryoprecipitate that could reduce deaths from hemorrhaging in trauma patients is being studied by researchers at The University of Texas Health Science Center at Houston (UTHealth) as part of an international trial. The UTHealth Center for Translational Injury Research is launching the Houston site of […]
  • Team is first in Texas to join NIH-sponsored study investigating efficacy of convalescent plasma for COVID-19 Transfusion of human plasma. Using a multimillion-dollar grant from the National Institutes of Health, physician-scientists at The University of Texas Health Science Center at Houston (UTHealth) will investigate whether convalescent plasma infusions can prevent the progression of COVID-19 in one of the first randomized clinical trials in the country. As part of the Center for Clinical and Translational Sciences, […]
  • Maternal obesity increases risk of potentially deadly hypertensive disorders early in pregnancy Pregnant woman with barefoot standing on weight scales. Care about body. Hands touching big belly. Close up. Point of view shot. Top view. Pregnant obese women were more at risk of experiencing early and late-onset hypertensive disorders, and that risk progressively increased in women with higher body mass indexes (BMI), according to a study led by researchers at The University of Texas Health Science Center at Houston (UTHealth). The retrospective cohort study was recently published in Obstetrics Gynecology. […]
  • Flu vaccine may reduce risk of Alzheimer’s disease, new study shows Nurse giving man vaccination People who received at least one flu vaccination were 17% less likely to get Alzheimer’s disease over the course of a lifetime, according to researchers at The University of Texas Health Science Center at Houston (UTHealth). First author Albert Amran, a fourth-year medical student at McGovern Medical School at UTHealth, presented the findings at the […]
  • Maternal depression increases odds of depression in offspring, study shows Upset little daughter looking at her pregnant mother's belly with jealousy Depression in mothers during and after pregnancy increased the odds of depression in offspring during adolescence and adulthood by 70%, according to a new study by researchers at The University of Texas Health Science Center at Houston (UTHealth). The systematic review was recently published in JAMA Network Open. It is the first study to examine […]
  • COVID-19 patient at LBJ Hospital recovers after convalescent plasma transfusion Mother Lying In Hospital Bed - In Labour Pain And In Discomfort. Using Nitrous Oxide More than a month after her battle with COVID-19, Kony Chacon enjoys spending time with newborn daughter and shows no ill effects from the virus that jeopardized her life and that of her unborn child. She credits a century-old treatment now being used to help coronavirus patients fight off the infection – convalescent blood plasma […]
  • Researchers study whether vadadustat, an investigational therapy, could mitigate acute lung injury in COVID-19 patients Doctor Woman holds Oxygen Mask for Inhale breath problem Patient, Coronavirus or Covid-19 attack Lungs. Healthcare worker in protective equipment put on oxygen mask patient diagnosis of coronavirus Physicians are studying whether vadadustat, an investigational therapy, could protect the lungs of COVID-19 patients by triggering the body’s protective response to low oxygen levels in a randomized Phase II clinical trial at The University of Texas Health Science Center at Houston (UTHealth). Vadadustat is designed to mimic the physiologic response to hypoxia (low oxygen). […]
  • UTHealth joins study of blood pressure medication’s effect on improving COVID-19 outcomes Emergency patient in critical state with intraaortic balloon pump and extracorporeal circuit hemodialysis assist An interventional therapy aimed at improving survival chances and reducing the need for critical care treatment due to COVID-19 is being investigated by physicians at The University of Texas Health Science Center at Houston (UTHealth). The clinical trial is underway at Memorial Hermann – Texas Medical Center and Harris Health System’s Lyndon B. Johnson Hospital. The […]
  • Simple blood test can predict severity of COVID-19 for some patients blood test tube An early prognosis factor that could be a key to determining who will suffer greater effects from COVID-19, and help clinicians better prepare for these patients, may have been uncovered by researchers at The University of Texas Health Science Center at Houston (UTHealth). Results of the findings were published today in the International Journal of […]
  • Team is first in Texas to investigate convalescent plasma for prevention of COVID-19 onset and progression Nurse at blood donation service with plasma donation A research team is the first in Texas to investigate whether plasma from COVID-19 survivors can be used in outpatient settings to prevent the onset and progression of the virus in two new clinical trials at The University of Texas Health Science Center at Houston (UTHealth). Convalescent Plasma to Stem Coronavirus will assess whether convalescent […]
  • Researchers uncover a critical early step of the visual process Extreme Close Up Of Eye Of Woman Against White Studio Background The key components of electrical connections between light receptors in the eye and the impact of these connections on the early steps of visual signal processing have been identified for the first time, according to research published today in Science Advances by The University of Texas Health Science Center at Houston (UTHealth). To understand fully […]
  • UTHealth joins trial of arthritis drug’s effect on COVID-19-induced cytokine storm Woman in medical uniform with x ray slide stock photo A drug is being studied for its effectiveness in treating a type of severe immune overreaction seen in patients with COVID-19-induced pneumonia by researchers at The University of Texas Health Science Center at Houston (UTHealth). The clinical trial is enrolling patients at Harris Health System’s Lyndon B. Johnson Hospital. The Phase III, multisite, randomized, double-blind, […]
  • Autopsy research aims to advance COVID-19 knowledge Image of Meena Bhattacharjee, MD, L. Maximilian Buja, MD, and Noah Reilly, DO in PPE. In an effort to continue fighting the global COVID-19 pandemic, a team of pathologists from The University of Texas Health Science Center at Houston (UTHealth) has documented the pathological findings from 23 autopsy patients with the disease in an upcoming issue of Cardiovascular Pathology, now available online. The study collated and summarized the findings of autopsy […]
  • New study reveals areas of brain where recognition and identification occur Image showing a map of the brain surface showing regions that preferentially activate during face (blue) and scene (red) identification. Using “sub-millimeter” brain implants, researchers at The University of Texas Health Science Center at Houston (UTHealth), have been able to determine which parts of the brain are linked to facial and scene recognition. The study was published today in Current Biology. “The ability to recognize familiar faces and locations is crucial to everyday life,” said Nitin […]
  • New chemotherapy drug studied for malignant brain tumor in children UTHealth neurosurgeon David Sandberg, MD, is leading a clinical trial investigating a new formulation of panobinostat for malignant pediatric brain tumors. (Photo by Children's Memorial Hermann Hospital) MTX110 is a new formulation of panobinostat, a chemotherapy drug that has shown promise in laboratory models of medulloblastoma, the most common malignant brain tumor in children. Now, MTX110 is the focus of a novel trial that places the therapy directly into the fourth ventricle of the brain to treat patients with recurrent medulloblastoma. According […]
  • Scientists and neurosurgeon team up to develop novel imaging device for babies with brain disorders Photo of Manish N. Shah, MD, holding the patient while the Cap-based Transcranial Optical Tomography captures whole-brain imaging in minutes. (Photo credit: Manish N. Shah, MD) Using night-vision goggle technology, near-infrared light, and high-resolution detectors, a wearable imaging device for awake infants with brain disorders was developed by a team of scientists and a pediatric neurosurgeon at The University of Texas Health Science Center at Houston (UTHealth). Cap-based Transcranial Optical Tomography (CTOT), which utilizes a cap for the baby’s head, is […]
  • Experts at UTHealth successfully treat severe case of COVID-19 in 3-week-old infant Mother Checks The Temperature Of A Sick Baby, newborn baby had a fever. Healthcare medical mother’s day concept In one of the first reported cases of its kind, a 3-week-old infant in critical condition recovered from COVID-19 due to rapid recognition and treatment by physicians from McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth). The case was published April 22 in the New England Journal of Medicine. […]
  • Researchers launch confidential helpline, 833-EMS-INTX, for Texas first responders to find help for substance use disorder Man using smartphone in bed late, in the middle of the night. Mobile phone in bedroom. First responders in Texas can now call a confidential helpline to seek treatment for substance use and mental health disorders through a new clinical research program at The University of Texas Health Science Center at Houston (UTHealth). The Heroes Helpline comes at a time when first responders are serving on the front lines of the […]
  • COVID-19 survivor donates plasma to help others recover from the virus Photo of Jose Abdelnoor, 71, donates his antibody-rich plasma after surviving COVID-19. (Photo credit: Jose Abdelnoor) Jose Abdelnoor, 71, and his wife Evelyn Diaz, 67, say they would go through the scary experience of having COVID-19 again if it means they could save a life through donating their antibody-rich plasma. “What greater gift is there to give someone than human life?” Diaz asked. Abdelnoor donated plasma through an experimental therapy program […]
  • Prev
  • 1
  • 2
  • 3
  • Next
UT Physicians A part of UTHealth

UT Professional Building
6410 Fannin Street | Houston, Texas 77030
888-4UT-DOCS (888-488-3627)

UT Physicians - facebook UT Physicians - instagram UT Physicians - twitter UT Physicians - linkedin UT Physicians - youtube

UT PHYSICIANS APP NOW AVAILABLE FOR DOWNLOAD

Downlaod the UT Physicians App on the Apple Store
Downlaod the UT Physicians App on Google Play

AN OFFICIAL ORTHOPEDIC AND SPORTS MEDICINE PROVIDER FOR

Houston Dynamo Logo
Houston Dash Logo

THE CLINICAL PRACTICE OF

McGovern Medical School at UTHealth
Contact / Feedback | Report Error | Patient Privacy | Web File Viewing | Site Policies | Employee Links

Copyright © 2018 to Present – The University of Texas Health Science Center at Houston (UTHealth)